Jump to content

Diethylstilbestrol disulfate

From Wikipedia, the free encyclopedia
(Redirected from MG-137)
Diethylstilbestrol disulfate
Clinical data
Trade namesHydroestryl, Idroestril
Other namesM.G. 137
Identifiers
  • [4-[(E)-4-(4-Sulfooxyphenyl)hex-3-en-3-yl]phenyl] hydrogen sulfate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.005.690 Edit this at Wikidata
Chemical and physical data
FormulaC18H20O8S2
Molar mass428.47 g·mol−1
3D model (JSmol)
  • CC/C(=C(/CC)\C1=CC=C(C=C1)OS(=O)(=O)O)/C2=CC=C(C=C2)OS(=O)(=O)O
  • InChI=1S/C18H20O8S2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12H,3-4H2,1-2H3,(H,19,20,21)(H,22,23,24)/b18-17+
  • Key:JQFXYBUUBRTZSR-ISLYRVAYSA-N

Diethylstilbestrol disulfate (brand names Hydroestryl, Idroestril; former developmental code name M.G. 137) is a synthetic, nonsteroidal estrogen of the stilbestrol group and an ester of diethylstilbestrol (DES) that was formerly marketed but is now no longer available.[1] It is described as an antineoplastic agent.[2]

References

[edit]
  1. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 396. ISBN 978-1-4757-2085-3.
  2. ^ Negwer M (1987). Organic-chemical drugs and their synonyms: (an international survey). VCH Publishers. p. 833. ISBN 978-0-89573-552-2.